Session Details

S048 Up-to-date Treatment of Hair, Scalp and Nail Disorders

Sun, Mar 9, 1:00 PM - 4:00 PM
W414B
3 CME Available Symposium
View Map

DESCRIPTION

This session is aimed to provide a very practical guide for the treatment of hair, scalp and nail disorders. It will discuss approved and off-label treatments for common and uncommon types of alopecia, and for common nail disorders. The session will discuss indications and efficacy of hair and nail procedures including intra-lesional injections, and lasers. It will also provide recommendations for treating and managing hair and nail disorders in patients of different ethnicities and genders, including transgender patients. Although focused to educate the younger audience, it will provide an up-to-date review for all providers.

LEARNING OBJECTIVES

1.

Select best treatment for the patients with different types of alopecia

2.

Differentiate procedures to utilize in patients with hair and nail disorders

3.

Select best treatment for patients with nail disorders

SCHEDULE

1:00 PM

Introduction

Antonella Tosti, MD, Brian William Morrison, MD, MSc, FAAD

1:05 PM

When a nail clipping is really important for treatment

Adam Rubin, MD, FAAD

1:11 PM

Nail lichen planus: new treatments

Matilde Iorizzo, PhD, MD, IFAAD

1:17 PM

Preventing and managing complications of nail surgery

Brian William Morrison, MD, MSc, FAAD

1:23 PM

Challenges in the treatment of nail warts

Shari Lipner, MD, PhD, FAAD

1:29 PM

Intralesional nail injections when and how

Bianca Maria Piraccini, MD, IFAAD

1:35 PM

Chemical matricectomy step by step

Bertrand Richert, MD, PhD, IFAAD

1:41 PM

My surgical tips

Martin N. Zaiac, MD, FAAD

1:47 PM

Questions and Answers

Matilde Iorizzo, PhD, MD, IFAAD, Shari Lipner, MD, PhD, FAAD, Brian William Morrison, MD, MSc, FAAD, Bianca Maria Piraccini, MD, IFAAD, Bertrand Richert, MD, PhD, IFAAD, Adam Rubin, MD, FAAD, Martin N. Zaiac, MD, FAAD

2:10 PM

Jak inhibitors in scarring alopecias

Maryanne Makredes Senna, MD, FAAD

2:16 PM

Actinic keratosis in the hairy scalp : how to treat

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

2:22 PM

FFA and cosmetic procedure

Antonella Tosti, MD

2:28 PM

Laser treatments in androgenetic alopecia

Yanna Kelly Barros, MD

2:34 PM

Hair oils : good or bad?

Boni E. Elewski, MD, FAAD

2:40 PM

Treating hair loss in women with cancer

Fernanda Torres, MD

2:46 PM

Haircare recommendation for women of African descent

Crystal Aguh, MD, FAAD

2:52 PM

Questions and Answers

Antonella Tosti, MD, Crystal Aguh, MD, FAAD, Boni E. Elewski, MD, FAAD, Yanna Kelly Barros, MD, Maryanne Makredes Senna, MD, FAAD, Natasha Atanaskova Mesinkovska, PhD, MD, FAAD, Fernanda Torres, MD

3:03 PM

Treatment of Central Centrifugal Cicatricial Alopecia

Amy J McMichael, MD, FAAD

3:09 PM

Intralesional injections in scarring alopecias

Jerry Shapiro, MD, FAAD

3:15 PM

Sublingual minoxidil

Rodney Daniel Sinclair, MD, IFAAD

3:21 PM

Treating of hair loss in transgender patients

Daniel Asz-Sigall, MD, IFAAD

3:27 PM

What’s new on antiandrogens

Maria Abril Martinez Velasco, MD

3:33 PM

Intralesional treatments in androgenetic alopecia

Sergio Vano-Galvan, MD, PhD, IFAAD

3:39 PM

Hair transplantation in scarring alopecia. When and how?

Ratchathorn Panchaprateep, MD, MSc

3:46 PM

Questions and Answers

Daniel Asz-Sigall, MD, IFAAD, Maria Abril Martinez Velasco, MD, Amy J McMichael, MD, FAAD, Ratchathorn Panchaprateep, MD, MSc, Jerry Shapiro, MD, FAAD, Rodney Daniel Sinclair, MD, IFAAD, Sergio Vano-Galvan, MD, PhD, IFAAD

DIRECTOR

Antonella Tosti, MD

Antonella Tosti, MD

SPEAKERS

Crystal Aguh, MD, FAAD

Crystal Aguh, MD, FAAD

Daniel Asz-Sigall, MD, IFAAD

Daniel Asz-Sigall, MD, IFAAD

Boni E. Elewski, MD, FAAD

Boni E. Elewski, MD, FAAD

Matilde Iorizzo, PhD, MD, IFAAD

Matilde Iorizzo, PhD, MD, IFAAD

Yanna Kelly Barros, MD

Yanna Kelly Barros, MD

Shari Lipner, MD, PhD, FAAD

Shari Lipner, MD, PhD, FAAD

Maryanne Makredes Senna, MD, FAAD

Maryanne Makredes Senna, MD, FAAD

Maria Abril Martinez Velasco, MD

Maria Abril Martinez Velasco, MD

Amy J McMichael, MD, FAAD

Amy J McMichael, MD, FAAD

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

Brian William Morrison, MD, MSc, FAAD

Brian William Morrison, MD, MSc, FAAD

Ratchathorn Panchaprateep, MD, MSc

Ratchathorn Panchaprateep, MD, MSc

Bianca Maria Piraccini, MD, IFAAD

Bianca Maria Piraccini, MD, IFAAD

Bertrand Richert, MD, PhD, IFAAD

Bertrand Richert, MD, PhD, IFAAD

Adam Rubin, MD, FAAD

Adam Rubin, MD, FAAD

Jerry Shapiro, MD, FAAD

Jerry Shapiro, MD, FAAD

Rodney Daniel Sinclair, MD, IFAAD

Rodney Daniel Sinclair, MD, IFAAD

Fernanda Torres, MD

Fernanda Torres, MD

Sergio Vano-Galvan, MD, PhD, IFAAD

Sergio Vano-Galvan, MD, PhD, IFAAD

Martin N. Zaiac, MD, FAAD

Martin N. Zaiac, MD, FAAD

HANDOUTS

Login to view handouts

DISCLOSURES

Crystal Aguh, MD, FAAD

CP Skin Health – Advisory Board(Honoraria); Eli Lilly and Company – Consultant(Fees); janssen – Other(Residency/Fellowship Program Funding); Myovant Sciences – Advisory Board(Fees); Olaplex – Advisory Board(Fees); Pfizer Inc. – Consultant(Fees); Procter & Gamble Company – Consultant (1099 relationship)(Fees); UpToDate, Inc – Other(Fees);

Daniel Asz-Sigall, MD, IFAAD

No financial relationships exist with ineligible companies.

Boni E. Elewski, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding);

Matilde Iorizzo, PhD, MD, IFAAD

Almirall – Speaker(Fees); Bailleul – Speaker(Fees); Janssen Pharmaceuticals, Inc – Other(Other Financial Benefit); Laboratoires Bailleul – Speaker(Fees); Leo Pharma – Advisory Board(Fees);

Yanna Kelly Barros, MD

L'Oreal – Speaker(Fees); Pfizer Inc. – Speaker(Fees); Pierre Fabre Dermatologie – Advisory Board(Fees);

Shari Lipner, MD, PhD, FAAD

BelleTorus Corporation – Investigator(Grants/Research Funding); Moberg Pharma North America LLC – Investigator(Grants/Research Funding);

Maryanne Makredes Senna, MD, FAAD

AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Fees); Cassiopia – Advisory Board(Fees); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); Concert Pharmaceuticals – Consultant(Fees); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Department Of Health and Human Services; Division of Vaccine Injury Compensation – Independent Contractor(Fees); Eli Lilly – Speaker(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Follica – Investigator(Equipment); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Other(Grants/Research Funding), Speaker(Fees); Q32 Bio Inc. – Investigator(Grants/Research Funding); Santiste Medical – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees);

Maria Abril Martinez Velasco, MD

No financial relationships exist with ineligible companies.

Amy J McMichael, MD, FAAD

Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);

Natasha Atanaskova Mesinkovska, PhD, MD, FAAD

AbbVie – Investigator(No Compensation Received); Arcutis, Inc. – Investigator(No Compensation Received); Arena Pharmaceuticals – Advisory Board(Honoraria), Investigator(No Compensation Received); Concert Pharmaceuticals – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Investigator(No Compensation Received); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(No Compensation Received); Merz Aesthetics – Investigator(Grants/Research Funding); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding);

Brian William Morrison, MD, MSc, FAAD

No financial relationships exist with ineligible companies.

Ratchathorn Panchaprateep, MD, MSc

No financial relationships exist with ineligible companies.

Bianca Maria Piraccini, MD, IFAAD

ISDIN – Consultant(Fees); L'Oréal France – Advisory Board(Fees); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);

Bertrand Richert, MD, PhD, IFAAD

No financial relationships exist with ineligible companies.

Adam Rubin, MD, FAAD

New York University Langone Medical Center – Employee – Lab does not sell products(Salary);

Jerry Shapiro, MD, FAAD

30 Madison – Consultant (1099 relationship)(Stock Options); Almirall – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria);

Rodney Daniel Sinclair, MD, IFAAD

AbbVie – Advisory Board(Fees); Aclaris Therapeutics Inc. – Investigator(Fees); Amgen – Investigator(Fees); Ascend Pharmaceuticals, Inc. – Board of Directors(Fees); Bayer – Speaker/Faculty Education(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Botaneco – Investigator(Fees); Celgene Corporation – Investigator(Fees); Coherus Biosciences – Investigator(Fees); CSL – Consultant(Fees); Cutanea Life Sciences – Investigator(Fees); Eli Lilly and Company – Advisory Board(Fees); GlaxoSmithKline – Investigator(Fees); inVentiv Health – Investigator(Fees); Janssen Pharmaceuticals, Inc – Other(Fees); Johnson & Johnson Pharmaceutical Research & Development – Investigator(Fees); Leo Pharma Inc – Advisory Board(Fees); Medimmune – Investigator(Fees); Medpace – Investigator(Fees); Merck & Co., Inc – Investigator(Fees); Merck Serono – Investigator(Fees); Novartis – Investigator(Fees); Pfizer Inc. – Advisory Board(Fees), Investigator(Fees); PhotonMD, Inc. – Investigator(Fees); PPD Inc. – Investigator(Fees); Principia Biopharma Inc – Investigator(Fees); Regeneron Pharmaceuticals, Inc. – Investigator(Fees); Reistone Biopharma – Investigator(Fees); Revian LTD. – Investigator(Fees); Samson Clinical – Founder(Patent royalties or other compensation for Intellectual Property Rights); UCB – Investigator(Fees);

Fernanda Torres, MD

No financial relationships exist with ineligible companies.

Antonella Tosti, MD

Almirall – Advisory Board(Fees); Amgen – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); L'Oreal USA Inc. – Advisory Board(Honoraria); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); The WellBeauty Company, LLC – Consultant (1099 relationship)(Fees); Thirty Madison, Inc. – Consultant(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);

Sergio Vano-Galvan, MD, PhD, IFAAD

AbbVie – Speaker(Fees); Cantabria Labs – Advisory Board(Fees); Fotofinder – Speaker(Fees); L'Oréal France – Advisory Board(Fees); Lilly ICOS LLC – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Fees);

Martin N. Zaiac, MD, FAAD

No financial relationships exist with ineligible companies.